These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 24551084)
21. Effect of the hydrophobic nature of triacetyl-beta-cyclodextrin on the complexation with nicardipine hydrochloride: physicochemical and dissolution properties of the kneaded and spray-dried complexes. Fernandes CM; Veiga FJ Chem Pharm Bull (Tokyo); 2002 Dec; 50(12):1597-602. PubMed ID: 12499598 [TBL] [Abstract][Full Text] [Related]
22. Characterization of Complexes between Imidacloprid and β-Cyclodextrin: Evaluation of the Toxic Activity in Algae and Rotifers. Lavorgna M; Dragone M; Russo C; D'Abrosca G; Nugnes R; Orlo E; Della Valle M; Isernia C; Malgieri G; Iacovino R; Isidori M Molecules; 2023 Mar; 28(7):. PubMed ID: 37049814 [TBL] [Abstract][Full Text] [Related]
23. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies. Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111 [TBL] [Abstract][Full Text] [Related]
24. Physico-chemical characterization and in vitro dissolution assessment of clonazepam-cyclodextrins inclusion compounds. Patel R; Purohit N AAPS PharmSciTech; 2009; 10(4):1301-12. PubMed ID: 19885735 [TBL] [Abstract][Full Text] [Related]
25. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation. Semalty M; Panchpuri M; Singh D; Semalty A Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445 [TBL] [Abstract][Full Text] [Related]
26. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery. Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714 [TBL] [Abstract][Full Text] [Related]
27. Encapsulation of Risperidone by Methylated β-Cyclodextrins: Physicochemical and Molecular Modeling Studies. Sbârcea L; Tănase IM; Ledeți A; Cîrcioban D; Vlase G; Barvinschi P; Miclău M; Văruţ RM; Trandafirescu C; Ledeți I Molecules; 2020 Dec; 25(23):. PubMed ID: 33287127 [TBL] [Abstract][Full Text] [Related]
28. Enhanced pharmacological efficacy of sumatriptan due to modification of its physicochemical properties by inclusion in selected cyclodextrins. Paczkowska M; Mizera M; Sałat K; Furgała A; Popik P; Knapik-Kowalczuk J; Krause A; Szymanowska-Powałowska D; Fojud Z; Kozak M; Paluch M; Cielecka-Piontek J Sci Rep; 2018 Nov; 8(1):16184. PubMed ID: 30385844 [TBL] [Abstract][Full Text] [Related]
29. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes. Desai C; Prabhakar B Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555 [TBL] [Abstract][Full Text] [Related]
30. Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin. Ribeiro A; Figueiras A; Santos D; Veiga F AAPS PharmSciTech; 2008; 9(4):1102-9. PubMed ID: 18975116 [TBL] [Abstract][Full Text] [Related]
31. Characterization and evaluation of synthetic riluzole with β-cyclodextrin and 2,6-di-O-methyl-β-cyclodextrin inclusion complexes. Wang L; Li S; Tang P; Yan J; Xu K; Li H Carbohydr Polym; 2015 Sep; 129():9-16. PubMed ID: 26050882 [TBL] [Abstract][Full Text] [Related]
32. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes. Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867 [TBL] [Abstract][Full Text] [Related]
33. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative. Jug M; Kosalec I; Maestrelli F; Mura P J Pharm Biomed Anal; 2011 Apr; 54(5):1030-9. PubMed ID: 21215544 [TBL] [Abstract][Full Text] [Related]
34. Solid-state characterization and in vitro dissolution behavior of lorazepam: Hydroxypropyl-β-cyclodextrin inclusion complex. Patel R; Patel M Drug Discov Ther; 2010 Dec; 4(6):442-52. PubMed ID: 22491310 [TBL] [Abstract][Full Text] [Related]
35. Succinyl-β-cyclodextrin: Influence of the substitution degree on albendazole inclusion complexes probed by NMR. Priotti J; García A; Leonardi D; Ferreira MJ; Lamas MC; Nunes TG Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():694-702. PubMed ID: 30184797 [TBL] [Abstract][Full Text] [Related]
36. Triamterene-beta-cyclodextrin systems: preparation, characterization and in vivo evaluation. Mukne AP; Nagarsenker MS AAPS PharmSciTech; 2004 Mar; 5(1):E19. PubMed ID: 15198540 [TBL] [Abstract][Full Text] [Related]
37. Salt screening and characterization for poorly soluble, weak basic compounds: case study albendazole. Paulekuhn GS; Dressman JB; Saal C Pharmazie; 2013 Jul; 68(7):555-64. PubMed ID: 23923637 [TBL] [Abstract][Full Text] [Related]
38. Enhanced dissolution and stability of lansoprazole by cyclodextrin inclusion complexation: preparation, characterization, and molecular modeling. Lu Y; Guo T; Qi J; Zhang J; Wu W AAPS PharmSciTech; 2012 Dec; 13(4):1222-9. PubMed ID: 22968546 [TBL] [Abstract][Full Text] [Related]
39. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin. Guo B; Zhong S; Li N; Li X; Yi J; Jin M Drug Dev Ind Pharm; 2013 Nov; 39(11):1638-43. PubMed ID: 24087855 [TBL] [Abstract][Full Text] [Related]